These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6625299

  • 21. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
    Tuxen DV, Powles AC, Mathur PN, Pugsley SO, Campbell EJ.
    Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
    [Abstract] [Full Text] [Related]

  • 22. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
    Jouve R, Puddu PE, Langlet F, Guillen JC, Gautier T, Cano JP, Serradimigni A.
    J Pharmacol; 1985 Mar; 16(2):139-57. PubMed ID: 3903352
    [Abstract] [Full Text] [Related]

  • 23. Favorable effects of hydralazine on the hemodynamic response to isometric exercise in chronic severe aortic regurgitation.
    Elkayam U, McKay CR, Weber L, Eisenberg D, Rahimtoola SH.
    Am J Cardiol; 1984 Jun 01; 53(11):1603-7. PubMed ID: 6731306
    [Abstract] [Full Text] [Related]

  • 24. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML, Sanford CF, Lipscomb KM.
    Am J Cardiol; 1985 Oct 01; 56(10):690-5. PubMed ID: 4050708
    [Abstract] [Full Text] [Related]

  • 25. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA, Chatterjee K, Ports TA, Gelberg HJ, Brundage BH, Parmley WW.
    Am J Cardiol; 1979 Nov 01; 44(6):1183-9. PubMed ID: 495513
    [Abstract] [Full Text] [Related]

  • 26. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
    Elkayam U, Weber L, McKay CR, Rahimtoola SH.
    Am J Cardiol; 1984 Jul 01; 54(1):126-31. PubMed ID: 6741802
    [Abstract] [Full Text] [Related]

  • 27. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K, Masuda K, Okumura M, Kadosawa T, Fujinaga T.
    J Vet Med Sci; 2001 Mar 01; 63(3):243-50. PubMed ID: 11307923
    [Abstract] [Full Text] [Related]

  • 28. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
    Magorien RD, Brown GP, Unverferth DV, Nelson S, Boudoulas H, Bambach D, Leier CV.
    Circulation; 1982 Mar 01; 65(3):528-33. PubMed ID: 7055874
    [Abstract] [Full Text] [Related]

  • 29. Echocardiographic and clinical effects of milrinone in dogs with myocardial failure.
    Kittleson MD, Pipers FS, Knauer KW, Keister DM, Knowlen GG, Miner WS.
    Am J Vet Res; 1985 Aug 01; 46(8):1659-64. PubMed ID: 4037492
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA, Pierpont G, Cohn JN.
    Ann Intern Med; 1977 Apr 01; 86(4):388-93. PubMed ID: 848799
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
    Rubin LJ, Handel F, Peter RH.
    Circulation; 1982 Jun 01; 65(7):1369-73. PubMed ID: 7074795
    [Abstract] [Full Text] [Related]

  • 36. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB, Gonik B, Dorman KF.
    Surg Gynecol Obstet; 1985 Sep 01; 161(3):240-4. PubMed ID: 4035539
    [Abstract] [Full Text] [Related]

  • 37. Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
    Wang SY, Manyari DE, Scott-Douglas N, Smiseth OA, Smith ER, Tyberg JV.
    Circulation; 1995 Feb 15; 91(4):1205-12. PubMed ID: 7850960
    [Abstract] [Full Text] [Related]

  • 38. Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.
    Ginks WR, Redwood DR.
    Br Heart J; 1980 Sep 15; 44(3):259-64. PubMed ID: 7426183
    [Abstract] [Full Text] [Related]

  • 39. Hemodynamic effects of nifedipine in congestive heart failure.
    Matsumoto S, Ito T, Sada T, Takahashi M, Su KM, Ueda A, Okabe F, Sato M, Sekine I, Ito Y.
    Am J Cardiol; 1980 Sep 15; 46(3):476-80. PubMed ID: 7415993
    [Abstract] [Full Text] [Related]

  • 40. Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine.
    Packer M, Gorlin R, Meller J, Medina N.
    Clin Pharmacol Ther; 1982 Jul 15; 32(1):54-61. PubMed ID: 7083730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.